ArticleJournal of fungi (Basel, Switzerland)2026
In Vitro Activity and In Vivo Efficacy in a Murine Model of Rezafungin, Anidulafungin, Caspofungin, and Micafungin Against the Fifth Clade of
Dávid Balázsi, Jacques F Meis, Jeffrey B Locke, Gergely Udvarhelyi, Zoltán Tóth, Lajos Forgács, Csaba Kósa, Renátó Kovács, László Majoros
Abstract read
In one paragraphArticle in Journal of fungi (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Dávid BalázsiDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary.
Jacques F MeisCentre of Expertise in Mycology, Radboudumc and Canisius Wilhelmina Hospital, 6525 GA Nijmegen, The Netherlands.ORCID 0000-0003-3253-6080 Jeffrey B LockeElion Therapeutics, Inc., 1 Lincoln Street, Suite 30-120, Boston, MA 02111, USA.
Gergely UdvarhelyiDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary.
Zoltán TóthDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary.
Lajos ForgácsDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary.
Csaba KósaDepartment of Surgery, Clinical Centre, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
Renátó KovácsDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary.ORCID 0000-0003-3946-2424 László MajorosDepartment of Medical Microbiology, Faculty of Medicine, University of Debrecen, Nagyerdei krt. 98, 4032 Debrecen, Hungary.
Funding
Hungarian Academy of Sciences Bo/00294/25National Research, Development and Innovation Office EKÖP-25-4-II-DE-59National Research, Development and Innovation Office FK138462National Research, Development and Innovation Office Starting 150834
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Candida aurisechinocandinsfifth cladeneutropenic mouse modelpseudohyphae productionrezafungintime–kill
Identifiers
PMID42646079
PMCPMC13514925
What OpenQuestion holds
Textmetadata
Read underepoch 390